Displaying publications 1 - 20 of 286 in total

Abstract:
Sort:
  1. KHOO FY
    Med J Malaya, 1955 Jun;9(4):281-3.
    PMID: 13253128
    Matched MeSH terms: Adenocarcinoma*
  2. MEARSES SD
    Med J Malaysia, 1963 Jun;17:253-62.
    PMID: 14065443
    Matched MeSH terms: Adenocarcinoma*
  3. Loke YW
    Br. J. Cancer, 1965 Sep;19(3):482-5.
    PMID: 5833066 DOI: 10.1038/bjc.1965.56
    Matched MeSH terms: Adenocarcinoma/pathology
  4. Snelling MR, Chooi MUN KAM
    Thorax, 1966 Sep;21(5):434-6.
    PMID: 5969242
    Matched MeSH terms: Adenocarcinoma/epidemiology*
  5. Loke YW
    Br. J. Cancer, 1967 Dec;21(4):665-74.
    PMID: 6074690
    Matched MeSH terms: Adenocarcinoma/epidemiology
  6. Dutt AK, Kutty MK
    Med J Malaya, 1969 Jun;23(4):298-9.
    PMID: 4242177
    Matched MeSH terms: Adenocarcinoma*
  7. Ang AH, Lambeth JT, Soo YS, Ong SC
    Med J Malaya, 1970 Sep;25(1):8-16.
    PMID: 4249503
    Matched MeSH terms: Adenocarcinoma/radiography
  8. Dharmalingam SK, Narasimha K
    Med J Malaya, 1972 Sep;27(1):73-6.
    PMID: 4264829
    Matched MeSH terms: Adenocarcinoma/diagnosis*
  9. Cunningham IG, Lee YK
    Aust N Z J Surg, 1975 Aug;45(3):285-9.
    PMID: 1058690
    A group of patients with solitary nodules of the thyroid were treated at the University of Malaya by surgery under local anaesthesia. This was done in order to expedite exploration of a potentially malignant condition. This group comprised 43 patients, and four cancers were found. The standard technique used was satisfactory from the viewpoint of both the patient and the surgeon. The pattern of this condition in a Malaysian population is documented, the technique used is described, and thyroidectomy under local aneaesthesia is discussed.
    Matched MeSH terms: Adenocarcinoma/pathology
  10. Ong HC, Chan WF, Sinnathuray TA
    Med J Malaysia, 1978 Mar;32(3):217-9.
    PMID: 683046
    Matched MeSH terms: Adenocarcinoma/pathology*
  11. Menon MA, Saw HS
    Thorax, 1979 Apr;34(2):269-73.
    PMID: 225839
    Between 1967 and 1976, 388 cases of lung cancer were seen at the University Hospital, Kuala Lumpur, with histological confirmation in 72%. Most were aged from 50--80, with a male to female ratio of 2.8 : 1. The patients were predominantly of Chinese origin (82%) and from the lower socioeconomic strata. A history of smoking was elicited in 78%. The chief clinical and radiological features and the diagnostic methods are presented. The incidence of the histological types was squamous carcinoma 34%, adenocarcinoma 25%, large cell carcinoma 12%, small (oat) cell carcinoma 12%, "unidifferentiated/anaplastic" 15%, and others 2%. Malays appeared to have a higher percentage of adenocarcinoma. A comparison between the histologically confirmed group and the rest showed no significant difference in features. Problems pertaining to the management of Malaysian patients are discussed.
    Matched MeSH terms: Adenocarcinoma/epidemiology
  12. Alif AK, Meah F
    Med J Malaysia, 1984 Jun;39(2):123-6.
    PMID: 6392839
    Matched MeSH terms: Adenocarcinoma/diagnosis
  13. Ng KH, Siar CH
    Med J Malaysia, 1986 Sep;41(3):213-9.
    PMID: 2444865
    The morphology, incidence and distribution of hyaline cells in ten cases each of pleomorphic adenoma, adenoid cystic carcinoma, adenocarcinoma and mucoepidermoid tumour were studied by conventional light microscopy. Results showed that the hyaline cells were identified in 60% of pleomorphic adenoma and in 20% of mucoepidermoid tumours, but were absent in adenoid cystic carcinoma and adenocarcinoma. Relative area estimation of hyaline cells in pleomorphic adenomas showed that this may range from 2.2% to 30.4% of the total tumour area. The usefulness of the hyaline cell as a diagnostic criteria in distinguishing between some of the salivary gland tumours was also discussed.
    Matched MeSH terms: Adenocarcinoma/pathology
  14. Menon MA
    Med J Malaysia, 1987 Sep;42(3):166-72.
    PMID: 3506638
    Matched MeSH terms: Adenocarcinoma/diagnosis; Adenocarcinoma/epidemiology*
  15. Gopal P, Iyawoo K, Hooi Lai Ngoh, Parameswary V
    Med J Malaysia, 1988 Dec;43(4):288-96.
    PMID: 2853822
    Matched MeSH terms: Adenocarcinoma/complications; Adenocarcinoma/epidemiology*
  16. Sivanesaratnam V
    Ann Acad Med Singap, 1989 Jan;18(1):75-9.
    PMID: 2712524
    One hundred years ago cervical cancer was rapidly fatal, regardless of therapy rendered. Today with cytological screening, early diagnosis is possible and ablative therapy can be instituted in appropriate cases. The advent of coloscopy has helped reduce unnecessary cone biopsy for diagnosis. However, the same cannot be said of the use of cytology for screening endometrial cancer, and often endometrial tissue biopsy is necessary. Ovarian cancer is notoriously silent in its early stages and symptoms if present are generally non-specific. To date there is no other useful and reliable method for its early detection than routine pelvic examination. An annual cytological screening test for cervical cancer will give an opportunity for examination of the breasts, abdomen and pelvis. Screening techniques for female genital tract malignancies are discussed.
    Matched MeSH terms: Adenocarcinoma/epidemiology
  17. Sivanesaratnam V, Jayalakshmi P
    Cancer, 1989 Aug 15;64(4):798-800.
    PMID: 2501019
    Patients undergoing radical surgical treatment for Stage IB and IIA cervical carcinoma are at high risk of developing local recurrence and/or distant metastases when one or more of the following factors are present: presence of metastatic pelvic lymph nodes, a large primary growth, full-thickness tumor invasion of the cervix, clinically undetected parametrial extension, and lymphatic/vascular channel permeation in the cervix by tumor cells. Carcinoma of the cervix appears to be behaving like a systemic disease. Therefore, systemic measures should be considered in its therapy. The authors report the initial experience with the use of mitomycin C as a single agent adjuvant in 16 patients with Stage IB carcinoma of the cervix who had undergone Wertheim radical hysterectomy and were thought to be in this high-risk group. Fourteen of the patients are alive and free of disease after durations of follow-up ranging from 16 to 38 months, the disease-free survival at a median follow-up of 29 months being 87.5%. One patient required discontinuation of adjuvant chemotherapy because of severe marrow toxicity; however, in view of the presence of a multiple risk factors, pelvic irradiation was given instead. She died 13 months later from disseminated disease. A second patient died 6 months later from congestive cardiac failure.
    Matched MeSH terms: Adenocarcinoma/drug therapy*; Adenocarcinoma/pathology; Adenocarcinoma/surgery
  18. Liam CK, Looi LM, Pailoor J, Alhady SF
    Ann Acad Med Singap, 1989 Nov;18(6):713-6.
    PMID: 2624423
    Three cases of progressive dyspnoea in young female adults due to pulmonary lymphangitic carcinomatosis are reported. The underlying primary neoplasm was gastric carcinoma in all 3 cases. The diagnosis was not suspected in 2 patients because of their young age.
    Matched MeSH terms: Adenocarcinoma/complications; Adenocarcinoma/secondary*
  19. Tharmaseelan NK, Sundralingam S
    Med J Malaysia, 1989 Dec;44(4):354-6.
    PMID: 2520049
    Adenocarcinoma of the fallopian tube is a rare clinical entity. The incidence of primary tubal carcinoma has been reported as varying from 0.1 to 1.0 percent of all gynaecological malignancies. In Malaysia the incidence is unknown. A case of primary adenocarcinoma of the fallopian tube is reported.
    Matched MeSH terms: Adenocarcinoma/diagnosis; Adenocarcinoma/pathology*; Adenocarcinoma/therapy
  20. Lee SM
    Singapore Med J, 1990 Jun;31(3):228-32.
    PMID: 2168091
    Twelve patients with advanced inoperable non-small cell lung cancer (NSCLC) were treated with mitomycin, vinblastine and cisplatin (MVP) combination chemotherapy. The overall response rate was 33% (4 partial responses and no complete response) with a median survival of seven months. One responder above subsequently achieved complete remission following successful resection of his tumour and is still alive 14 months after initial chemotherapy. Responses were observed in patients with good performance status and limited disease. Side-effects were generally well tolerated and manageable. MVP is an effective regimen and the low response rate achieved here as compared to other centres is also discussed.
    Matched MeSH terms: Adenocarcinoma/drug therapy*
Filters
Contact Us

Please provide feedback to Administrator (afdal@afpm.org.my)

External Links